Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
The mineralocorticoid hormone aldosterone (Aldo) has been intensively studied for its ability to influence both the physiology and pathophysiology of the cardiovascular system. Indeed, although research on Aldo actions for decades has mainly focused on its effects in the kidney, several lines of evi...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2018/1204598 |
id |
doaj-82e9bb37da514b3199cd165b8271db98 |
---|---|
record_format |
Article |
spelling |
doaj-82e9bb37da514b3199cd165b8271db982020-11-25T01:41:36ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09001942-09942018-01-01201810.1155/2018/12045981204598Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and PathophysiologyAlessandro Cannavo0Leonardo Bencivenga1Daniela Liccardo2Andrea Elia3Federica Marzano4Giuseppina Gambino5Maria Loreta D’Amico6Claudia Perna7Nicola Ferrara8Giuseppe Rengo9Nazareno Paolocci10Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, USADepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyIstituti Clinici Scientifici Maugeri SpA, Telese Terme, ItalyIstituti Clinici Scientifici Maugeri SpA, Telese Terme, ItalyDepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, Naples, ItalyDivision of Cardiology, Johns Hopkins University, Baltimore, MD, USAThe mineralocorticoid hormone aldosterone (Aldo) has been intensively studied for its ability to influence both the physiology and pathophysiology of the cardiovascular system. Indeed, although research on Aldo actions for decades has mainly focused on its effects in the kidney, several lines of evidence have now demonstrated that this hormone exerts disparate extrarenal adverse effects, especially in the circulatory system. Accordingly, in the last lusters, a number of studies in preclinical models (in vitro and in vivo) and in humans have established that Aldo, following the interaction with its receptor—the mineralocorticoid receptor (MR)—is able to activate specific intracellular genomic and nongenomic pathways, thus regulating the homeostasis of the cardiovascular system. Importantly, through this mechanism of action, this hormone becomes a crucial regulator of the function and growth of different types of cells, including fibroblasts, cardiomyocytes, and vascular cells. For this main reason, it is plausible that when Aldo is present at high levels in the blood, it profoundly modifies the physiology of these cells, therefore being at the foundation of several cardiovascular disorders, such as heart failure (HF). On these grounds, in this review, we will provide an updated account on the current knowledge concerning Aldo activity in the cardiovascular system and the most recent preclinical studies and clinical trials designed to test better approaches able to counter the hyperactivity of the Aldo/MR signaling pathway in the setting of cardiovascular diseases.http://dx.doi.org/10.1155/2018/1204598 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alessandro Cannavo Leonardo Bencivenga Daniela Liccardo Andrea Elia Federica Marzano Giuseppina Gambino Maria Loreta D’Amico Claudia Perna Nicola Ferrara Giuseppe Rengo Nazareno Paolocci |
spellingShingle |
Alessandro Cannavo Leonardo Bencivenga Daniela Liccardo Andrea Elia Federica Marzano Giuseppina Gambino Maria Loreta D’Amico Claudia Perna Nicola Ferrara Giuseppe Rengo Nazareno Paolocci Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology Oxidative Medicine and Cellular Longevity |
author_facet |
Alessandro Cannavo Leonardo Bencivenga Daniela Liccardo Andrea Elia Federica Marzano Giuseppina Gambino Maria Loreta D’Amico Claudia Perna Nicola Ferrara Giuseppe Rengo Nazareno Paolocci |
author_sort |
Alessandro Cannavo |
title |
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
title_short |
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
title_full |
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
title_fullStr |
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
title_full_unstemmed |
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
title_sort |
aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology |
publisher |
Hindawi Limited |
series |
Oxidative Medicine and Cellular Longevity |
issn |
1942-0900 1942-0994 |
publishDate |
2018-01-01 |
description |
The mineralocorticoid hormone aldosterone (Aldo) has been intensively studied for its ability to influence both the physiology and pathophysiology of the cardiovascular system. Indeed, although research on Aldo actions for decades has mainly focused on its effects in the kidney, several lines of evidence have now demonstrated that this hormone exerts disparate extrarenal adverse effects, especially in the circulatory system. Accordingly, in the last lusters, a number of studies in preclinical models (in vitro and in vivo) and in humans have established that Aldo, following the interaction with its receptor—the mineralocorticoid receptor (MR)—is able to activate specific intracellular genomic and nongenomic pathways, thus regulating the homeostasis of the cardiovascular system. Importantly, through this mechanism of action, this hormone becomes a crucial regulator of the function and growth of different types of cells, including fibroblasts, cardiomyocytes, and vascular cells. For this main reason, it is plausible that when Aldo is present at high levels in the blood, it profoundly modifies the physiology of these cells, therefore being at the foundation of several cardiovascular disorders, such as heart failure (HF). On these grounds, in this review, we will provide an updated account on the current knowledge concerning Aldo activity in the cardiovascular system and the most recent preclinical studies and clinical trials designed to test better approaches able to counter the hyperactivity of the Aldo/MR signaling pathway in the setting of cardiovascular diseases. |
url |
http://dx.doi.org/10.1155/2018/1204598 |
work_keys_str_mv |
AT alessandrocannavo aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT leonardobencivenga aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT danielaliccardo aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT andreaelia aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT federicamarzano aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT giuseppinagambino aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT marialoretadamico aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT claudiaperna aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT nicolaferrara aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT giusepperengo aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology AT nazarenopaolocci aldosteroneandmineralocorticoidreceptorsystemincardiovascularphysiologyandpathophysiology |
_version_ |
1725040808436957184 |